8Jorda M, Ganjei AP, Nadji M. Cytologic characteristics ofmen ingeal carcinomatosis: increased diagnostic accuracy using carci noembryonic antigenand epithelial membrane antigen immunoocy tochemistry[J]. Arch Neurol, 1998, 5 (2): 181-184.
9Oschmann P, Kaps M, Volker J, et al. Meningeal carcinomatosis: CSF cytology, immunocytochemistry and biochemical tumor markers [J]. Acta NeurolScand, 1994, 89 (5): 395-399.
10Lee Ct, Fan FS, Chen PM, et al. The application of any immunocytochemistry in diagnosisofmeningeal carcinomatosis in a patientwith unkonownprimary site [J].ChungHua I Huseh ChihTiapei, 1992, 50 (7): 429-433.
4[2]Jorda M,Ganjei AP,Nadji M.Cytologic characteristics of meningeal carcinomatosis:increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunoocytochemistry.Arch Neurol,1998,5(2):181-184.
5[4]Lee CT,Fan FS,Chen PM,et al.The application of any immunocytochemistry in diagnosis of meningeal carcinomatosis in a patient with unkonown primary site.Chung Hua I Huseh Chih Tiapei,1992,50(7):429-433.
7[6]Castro MP,Mc Donald TJ,Qualman SJ,et al.Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma.Cancer,2001,91(11):2 122-2 126.
1Pavlidis N. The diagnostic and therapeutic managem ent of leptomeningeal carcinomatosis[J].Annals of Oncology,2004,(Suppl 4):285-291.
2DemopoulosA. Leptomeningeal metastases[J].Current Neurology and Neuroscience Reports,2004,(03):196-204.
3Gerrard GE,Franks KN. Overview of the diagnosis and management of brain,spine and meningeal metastases[J].Journal of Neurology, Neurosurgery & Psychiatry,2004,(Suppl 2):38.doi:10.1016/j.bbrc.2009.02.082.
